Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-98-004071
Filing Date
1998-06-29
Accepted
1998-06-29 00:00:00
Documents
12
Period of Report
1998-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ALKERMES INC. 10-K405 237579
2 REGISTRATION RIGHTS AGREEMENT EX-4.12 75671
3 AMENDED & RESTATED 1990 OMNIBUS STOCK OPTION PLAN EX-10.2 27361
4 DEVELOPMENT AND LICENSE AGREEMENT EX-10.25 103078
5 SUPPLY & LICENSE AGREEMENT EX-10.26 46855
6 2ND LOAN SUPPLEMENT & MODIFICATION AGREEMENT EX-10.29(B) 158809
7 PROMISSORY NOTE DATED 3/19/98 EX-10.38 8585
8 STATEMENT RE: COMPUTATION OF PER SHARE LOSS EX-11 1604
9 SUBSIDIARIES EX-21 1004
10 PROXY STATEMENT EX-22 67245
11 CONSENT OF DELOITTE & TOUCHE EX-23 561
12 FINANCIAL DATA SCHEDULE EX-27 2360
  Complete submission text file 0000950135-98-004071.txt   733212
Mailing Address
Business Address 64 SIDNEY ST CAMBRIDGE MA 02139-4136 6174940171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K405 | Act: 34 | File No.: 001-14131 | Film No.: 98656891
SIC: 2834 Pharmaceutical Preparations